Reproducibility of Glycemic Measures Among Dysglycemic Youth and Adults in the RISE Study
- PMID: 36938582
- PMCID: PMC10505524
- DOI: 10.1210/clinem/dgad135
Reproducibility of Glycemic Measures Among Dysglycemic Youth and Adults in the RISE Study
Abstract
Aims: Previous work found poor reproducibility for measures of glycemia in individuals at risk for dysglycemia. Differences between youth and adults have not been assessed. Using youth and adults in the Restoring Insulin Secretion Study, we tested variability and classification concordance for hemoglobin A1C (HbA1c), fasting and 2-hour glucose from oral glucose tolerance tests (OGTTs).
Methods: HbA1c and glucose on repeated samples obtained ∼6 weeks apart were compared in 66 youth (mean age 14.2 years) and 354 adults (52.7 years). Changes, coefficient of variation (CV), and concordance of diagnostic categories between the 2 visits were compared.
Results: Mean difference between the 2 visits in HbA1c was higher in youth than adults (P < .001), while fasting glucose was similar and 2-hour glucose was lower in youth (P = .051). CV was smallest for HbA1c compared to fasting and 2-hour glucose. For HbA1c, youth had higher CV (P < .001); whereas CV for 2-hour glucose was lower for youth (P = .041). Classification concordance by HbA1c was lower in youth (P = .004). Using OGTT or HbA1c for classification, intervisit variability produced discordant classification in 20% of youth and 28% of adults. Using both fasting glucose and HbA1c, intervisit variability reduced discordant classification to 16% of adults while not improving classification in youth.
Conclusions: Poor reproducibility and lack of classification concordance highlight the limitations of one-time testing, with important implications for assessing eligibility in clinical trials. Consideration should be given to using more than a single parameter for screening and diagnosis, especially when classification category is important.
Trial registration: ClinicalTrials.gov NCT01779362 NCT01779375 NCT01763346.
Keywords: HbA1c; classification criteria; coefficient of variation; diagnosis and classification; oral glucose tolerance test; reproducibility.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 DK094431/DK/NIDDK NIH HHS/United States
- P30 DK020595/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
- P30 DK097512/DK/NIDDK NIH HHS/United States
- U01 DK094430/DK/NIDDK NIH HHS/United States
- P30 DK116073/DK/NIDDK NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- UL1 TR001855/TR/NCATS NIH HHS/United States
- U01 DK094467/DK/NIDDK NIH HHS/United States
- U01 DK094438/DK/NIDDK NIH HHS/United States
- P30 DK048520/DK/NIDDK NIH HHS/United States
- UL1 TR000430/TR/NCATS NIH HHS/United States
- TL1 TR001858/TR/NCATS NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- U01-DK-094406/NH/NIH HHS/United States
- P30 DK045735/DK/NIDDK NIH HHS/United States
- UL1 TR001857/TR/NCATS NIH HHS/United States
